ARTICLE | Company News

Basilea, J&J sales and marketing update

September 13, 2010 7:00 AM UTC

In June, CHMP of the European Medicines Agency (EMA) issued a second negative opinion for an MAA, while FDA issued a second complete response letter last December for an NDA for the broad spectrum ant...